The functional loss of mutated FAT1 has also been reported to be associated with YAP1 activation in head and neck cancer (Martin et al., 2018), however, no enrichment of FAT1 mutation was seen among the YAP1-dependent nor WWTR1-dependent models in this study. This evidence concerns the gene YAP1 and head and neck cancer.